Literature DB >> 1255856

Gene 32 protein of bacteriophage T4 moderates the activities of the T4 gene 46/47-controlled nuclease and of the Escherichia coli RecBC nuclease in vivo.

G Mosig, S Bock.   

Abstract

Genes 46 and 47 of phage T4 control a nuclease that is required for genetic recombination and may act similarly to the Escherichia coli RecBC nuclease. In vivo, the nucleolytic activities of both of these nucleases must be moderated so that recombining DNA intermediates are not destroyed. We conclude from our present experiments that the phage T4 gene 32 protein, specifically its C-terminal domain, participates in such moderation. We have investigated DNA degradation in different gene 32 and gene 32/46 mutants under conditions that are completely restrictive for progeny production in all the mutants. Under these conditions, DNA of those gene 32 mutants in which the C-terminal domain of the protein is not synthesized or is modified is degraded to acid-soluble material. T4 gene 46 or E. coli recB mutations reduce such degradation; together they abolish it completely. By contrast, single gene 32 mutants which produce an unaltered C-terminal domain show little or no degradation of their DNA. Residual protection against nucleases is unrelated to residual primary DNA replication or to overproduction of the mutant peptides in the different gene 32 mutants.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1255856      PMCID: PMC515474          DOI: 10.1128/JVI.17.3.756-761.1976

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Transfection of Escherichia coli spheroplasts. V. Activity of recBC nuclease in rec+ and rec minus spheroplasts measured with different forms of bacteriophage DNA.

Authors:  R Benzinger; L W Enquist; A Skalka
Journal:  J Virol       Date:  1975-04       Impact factor: 5.103

2.  Structural genes of ATP-dependent deoxyribonuclease of Escherichia coli.

Authors:  J Tomizawa; H Ogawa
Journal:  Nat New Biol       Date:  1972-09-06

3.  On the exonuclease activity of phage T4 deoxyribonucleic acid polymerase.

Authors:  W M Huang; I R Lehman
Journal:  J Biol Chem       Date:  1972-05-25       Impact factor: 5.157

4.  Regulation of the synthesis of bacteriophage T4 gene 32 protein.

Authors:  H M Krisch; A Bolle; R H Epstein
Journal:  J Mol Biol       Date:  1974-09-05       Impact factor: 5.469

5.  Degradation of cytosin-containing bacterial and bacteriophage DNA after infection of Escherichia coli B with bacteriophage T4D wild type and with mutants defective in genes 46, 47 and 56.

Authors:  E M Kutter; J S Wiberg
Journal:  J Mol Biol       Date:  1968-12       Impact factor: 5.469

6.  Purification and properties of the gamma-protein specified by bacteriophage lambda: an inhibitor of the host RecBC recombination enzyme.

Authors:  Y Sakaki; A E Karu; S Linn; H Echols
Journal:  Proc Natl Acad Sci U S A       Date:  1973-08       Impact factor: 11.205

7.  Molecular mechanisms of genetic recombination in bacteriophage. VI. A mutant defective in the joining of DNA molecules.

Authors:  J I Tomizawa; N Anraku; Y Iwama
Journal:  J Mol Biol       Date:  1966-11-14       Impact factor: 5.469

8.  Mutants of bacteriophage T4 unable to cause breakdown of host DNA.

Authors:  J S Wiberg
Journal:  Proc Natl Acad Sci U S A       Date:  1966-03       Impact factor: 11.205

Review 9.  Recombination deficient mutants of E. coli and other bacteria.

Authors:  A J Clark
Journal:  Annu Rev Genet       Date:  1973       Impact factor: 16.830

10.  Genetic evidence for an additional function of phage T4 gene 32 protein: interaction with ligase.

Authors:  G Mosig; A M Breschkin
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

View more
  13 in total

1.  Biochemical characterization of bacteriophage T4 Mre11-Rad50 complex.

Authors:  Timothy J Herdendorf; Dustin W Albrecht; Stephen J Benkovic; Scott W Nelson
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

2.  Anecdotal, historical and critical commentaries on genetics. Gisela Mosig.

Authors:  Nancy G Nossal; Jeffrey L Franklin; Elizabeth Kutter; John W Drake
Journal:  Genetics       Date:  2004-11       Impact factor: 4.562

3.  Multiple interactions of a DNA-binding protein in vivo. III. Phage T4 gene-32 mutations differentially affect insertion-type recombination and membrane properties.

Authors:  G Mosig; W Berquist; S Bock
Journal:  Genetics       Date:  1977-05       Impact factor: 4.562

Review 4.  Bacteriophage T4 genome.

Authors:  Eric S Miller; Elizabeth Kutter; Gisela Mosig; Fumio Arisaka; Takashi Kunisawa; Wolfgang Rüger
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

Review 5.  Shutoff of host macromolecular synthesis after T-even bacteriophage infection.

Authors:  J F Koerner; D P Snustad
Journal:  Microbiol Rev       Date:  1979-06

6.  Amino acid sequence of the T4 DNA helix-destabilizing protein.

Authors:  K R Williams; M B LoPresti; M Setoguchi; W H Konigsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

7.  On the role of the single-stranded DNA binding protein of bacteriophage T4 in DNA metabolism. I. Isolation and genetic characterization of new mutations in gene 32 of bacteriophage T4.

Authors:  D H Doherty; P Gauss; L Gold
Journal:  Mol Gen Genet       Date:  1982

8.  Two alternative mechanisms for initiation of DNA replication forks in bacteriophage T4: priming by RNA polymerase and by recombination.

Authors:  A Luder; G Mosig
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

9.  Two recombination-dependent DNA replication pathways of bacteriophage T4, and their roles in mutagenesis and horizontal gene transfer.

Authors:  G Mosig; J Gewin; A Luder; N Colowick; D Vo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-17       Impact factor: 11.205

10.  Semiconservative DNA replication is initiated at a single site in recombination-deficient gene 32 mutants of bacteriophage T4.

Authors:  R Dannenberg; G Mosig
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.